Abstract
In 1967 Thomas Starzl performed the first orthotopic liver transplant (OLT) in Denver. Since 1990 OLT has been the main therapy for every form of terminal liver failure, including hepatocellular carcinoma (HCC). In 1996 Mazzaferro published the results obtained on selected patients affected with HCC. He showed a 4 year survival rate of 75%, comparable to the rate obtained on patients who were transplanted for non tumoral pathology (78.3%) [1].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrosi. N Engl J Med 334:693
Yao FY, Ferrel L, Bass NM et al (2001) Liver transplantation for hepatocellular carcinoma: expansion of tumor size limits does not adversely impact survival. Hepatology 33:1394
Llovet JM, Bruix J (2008) Molecular targeted therapies in hepatocellular carcinoma. Hepatology 48:1312–1327
Ringe B, Wittekind C, Weimann A et al (1992) Results of hepatic resection and transplantation for fibrolamellar carcinoma. Surg Gynecol Obstet 175:299–305
El Gazzaz G, Wong W, El Hadary MK et al (2000) Outcome of liver resection and transplantation for fibrolamellar hepatocellular carcinoma. Transpl Int 13[Suppl 1]:S406–S409
Schlitt HJ, Neipp M, Weimann A et al (1999) Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol 17:324–331
Otte JB, de Ville de Goyet J (2005) The contribution of transplantation to the treatment of liver tumors in children. Semin Pediat Surg 14:233–238
Otte JB, Prichard J, Arason DC et al (2004) Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL 1 and review of the world experience. Pediatr Blood Cancer 452:74–83
Jonas S, Benckert C, Thelen A et al (2008) Radical surgery for hilar cholangiocarcinoma. Eur J Surg Oncol 34:263–271
De Vreede I, Steers JL, Burch PA et al (2000) Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 6:309–316
Rosenau J, Bahr MJ, von Wasielewski R et al (2002) Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation 73:386–394
Coppa J, Pulvirenti A, Schiavo M et al (2001) Resection versus transplantation for liver metastases from neuroendocrine tumors. Transplant Proc 33:1537–1539
Cahlin C, Friman S, Ahlman H et al (2003) Liver transplantation for metastatic neuroendocrine tumor disease. Transpl Proc 35:809–810
Cameron S, Ramadori G, Fuzesi L et al (2005) Successful liver transplantation in two cases of metastatic gastrointestinal stromal tumor. Transplantation 2005:80 283–284
Monaco AP (2009) The role of mTOR inhibitors in the management of posttransplant malignancy. Transplantation 87:157–163
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Italia
About this chapter
Cite this chapter
Salizzoni, M., Carbonaro, G., Repetto, L. (2010). Transplants in Surgical Oncology. In: Mussa, A. (eds) New Technologies in Surgical Oncology. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-1475-6_10
Download citation
DOI: https://doi.org/10.1007/978-88-470-1475-6_10
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-1474-9
Online ISBN: 978-88-470-1475-6
eBook Packages: MedicineMedicine (R0)